Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

EBV- DNA Viral Load in Peripheral Blood Mononuclear Cells of Patients with Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognosis

Jacek Rolinski, MD PhD, Ewelina Grywalska, MD PhD, Marcin Pasiarski, MD PhD, Agnieszka Stelmach-Goldys, MD PhD, Agata Surdacka, Maciej Maj, Stanislaw Gozdz, MD PhD

Blood (2014) 124 (21): 1965.

https://doi.org/10.1182/blood.V124.21.1965.1965

Published: 2014

Journal Articles

CD1d Expression Is Higher In Chronic Lymphocytic Leukemia Patients With Unfavorable Prognosis

Agnieszka Bojarska-Junak, Iwona Hus, Anna Dmoszynska, Jacek Rolinski

Blood (2013) 122 (21): 5278.

https://doi.org/10.1182/blood.V122.21.5278.5278

Published: 2013

Journal Articles

Identification of RHAMM-Derived CD8 + Restricted, Heteroclitical, Cryptic Epitope R9Y as a Promising Target for Immunotherapy of Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, Anna Dmoszynska, Jacek Rolinski, Jochen Greiner, Stephan Stilgenbauer, Michael Schmitt

Blood (2009) 114 (22): 3034.

https://doi.org/10.1182/blood.V114.22.3034.3034

Published: 2009

Journal Articles

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

Krzysztof Giannopoulos, MD, PhD, Malgorzata Kowal, Anna Dmoszynska, MD, PhD, Jacek Rolinski, Kamila Mazurek, Jochen Greiner, Markus Rojewski, Stephan Stilgenbauer, Hartmut Döhner, Michael Schmitt

Blood (2008) 112 (11): 3159.

https://doi.org/10.1182/blood.V112.11.3159.3159

Published: 2008

Journal Articles

Molecular and Immunological Effects of Thalidomide in Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, Anna Dmoszynska, Malgorzata Kowal, Ewa Wasik-Szczepanek, Paulina Wlasiuk, Agnieszka Bojarska-Junak, Jacek Rolinski, Hartmut Döhner, Stephan Stilgenbauer, Lars Bullinger

Blood (2008) 112 (11): 2092.

https://doi.org/10.1182/blood.V112.11.2092.2092

Published: 2008

Journal Articles

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM): Characterization as an Immunotherapeutical Target in Chronic Lymphocytic Leukemia (CLL) and First Results of RHAMM-Derived Peptide Vaccination Trial.

Krzysztof Giannopoulos, MD, PhD, Andreas Buhler, MD, PhD, Jinfei Chen, MD, PhD, Alexander Krober, MD, PhD, Malgorzata Kowal, MD, PhD, Anna Dmoszynska, MD, PhD, Jacek Rolinski, MD, PhD, Jochen Greiner, MD, PhD, Hartmut Dohner, MD, PhD, Stephan Stilgenbauer, MD, PhD, Michael Schmitt, MD, PhD

Blood (2007) 110 (11): 2051.

https://doi.org/10.1182/blood.V110.11.2051.2051

Published: 2007

Journal Articles

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Iwona Hus, MD, PhD, Michael Schmitt, MD, PhD, Jacek Tabarkiewicz, MD, PhD, Sebastian Radej, MD, Agnieszka Bojarska-Junak, PhD, Kamila Wojas, PhD, Anita Schmitt, MD, PhD, Krzysztof Giannopoulos, MD, PhD, Anna Dmoszynska, MD, PhD, Jacek Rolinski, MD, PhD

Blood (2007) 110 (11): 2052.

https://doi.org/10.1182/blood.V110.11.2052.2052

Published: 2007

Journal Articles

Thalidomide Alone and in Combination with Fludarabine Exerts Distinct Molecular and Antileukemic Effects in B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, MD, PhD, Anna Dmoszynska, MD, PhD, Malgorzata Kowal, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Paulina Wlasiuk, MA, Agnieszka Bojarska-Junak, PhD, Jacek Rolinski, MD, PhD, Stephan Stilgenbauer, MD, PhD, Lars Bullinger, MD, PhD

Blood (2007) 110 (11): 3124.

https://doi.org/10.1182/blood.V110.11.3124.3124

Published: 2007

Journal Articles

RHAMM/CD168 Is a Novel Leukemia Associated Antigen with Prognostic Value for Patients with B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, MD, PhD, Alexander Krober, MD, Anna Dmoszynska, Jacek Rolinski, Hartmut Dohner, Stephan Stilgenbauer, Michael Schmitt, MD PhD

Blood (2006) 108 (11): 2773.

https://doi.org/10.1182/blood.V108.11.2773.2773

Published: 2006

Journal Articles

Clinical Efficacy and Safety of Combined Thalidomide and Fludarabine Therapy in B-Cell Chronic Lymphocytic Leukemia Patients.

Anna Dmoszynska, Krzysztof Giannopoulos, MD, PhD, Malgorzata Kowal, MD, PhD, Monika Podhorecka, MD, PhD, Paulina Wlasiuk, MSc, Agnieszka Bojarska-Junak, PhD, Wioletta Trzesniewska, MD, Jacek Rolinski

Blood (2006) 108 (11): 4975.

https://doi.org/10.1182/blood.V108.11.4975.4975

Published: 2006

Journal Articles

High Frequency of T Regulatory Cells in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Is Decreased by Thalidomide and Fludarabine Treatment.

Krzysztof Giannopoulos, MD, PhD, Michael Schmitt, MD PhD, Paulina Wlasiuk, MS C, Malgorzata Kowal, MD PhD, Monika Podhorecka, MD PhD, Jacek Rolinski, Anna Dmoszynska

Blood (2006) 108 (11): 2108.

https://doi.org/10.1182/blood.V108.11.2108.2108

Published: 2006

Journal Articles

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM/CD168) Is a Potential Target for Immunotherapy of Patients with B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, MD, Iwona Hus, PhD, Li Li, MD, Agnieszka Bojarska-Junak, PhD, Jochen Greiner, MD, Jacek Rolinski, PhD, Anna Dmoszynska, PhD, Hartmut Doehner, MD, Michael Schmitt, MD

Blood (2005) 106 (11): 53.

https://doi.org/10.1182/blood.V106.11.53.53

Published: 2005

Journal Articles

ZAP-70 Versus CD38 Expression as the Prognostic Factors in B-Cell Chronic Lymphocytic Leukemia.

Iwona Hus, MD, PhD, Agnieszka Bojarska-Junak, MD, PhD, Monika Podhorecka, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Malgorzata Sieklucka, MD, Katarzyna Skorzynska, MD, Jacek Rolinski, MD, PhD, Anna Dmoszynska, MD, PhD

Blood (2004) 104 (11): 4780.

https://doi.org/10.1182/blood.V104.11.4780.4780

Published: 2004

Journal Articles

Plasma and Intracellular Concentration of TNF and Its Receptors in Peripheral Blood and Bone Marrow in Different Stages of B-CLL.

Jacek Rolinski, MD, PhD, Agnieszka Bojarska-Junak, MD, PhD, Iwona Hus, MD, PhD, Anna Dmoszynska, MD, PhD

Blood (2004) 104 (11): 4781.

https://doi.org/10.1182/blood.V104.11.4781.4781

Published: 2004

Journal Articles

Dendritic Cells (DC) Generated from AML Blasts Express Leukemia Associated Antigens Eliciting Specific Cytotoxic T Cell Responses in the Autologous Host after DC Vaccination.

Li Li, PhD, Peter Reinhardt, MD, Iwona Hus, MD, Jacek Rolinski, MDPhD, Anna Dmoszynska, MDPhD, Markus Wiesneth, MD, Hartmut Dohner, MDPhD, Michael Schmitt, MDPhD

Blood (2004) 104 (11): 1812.

https://doi.org/10.1182/blood.V104.11.1812.1812

Published: 2004

NARROW

EBV- DNA Viral Load in Peripheral Blood Mononuclear Cells of Patients with Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognosis

CD1d Expression Is Higher In Chronic Lymphocytic Leukemia Patients With Unfavorable Prognosis

Identification of RHAMM-Derived CD8 + Restricted, Heteroclitical, Cryptic Epitope R9Y as a Promising Target for Immunotherapy of Chronic Lymphocytic Leukemia.

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

Molecular and Immunological Effects of Thalidomide in Chronic Lymphocytic Leukemia.

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM): Characterization as an Immunotherapeutical Target in Chronic Lymphocytic Leukemia (CLL) and First Results of RHAMM-Derived Peptide Vaccination Trial.

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Thalidomide Alone and in Combination with Fludarabine Exerts Distinct Molecular and Antileukemic Effects in B-Cell Chronic Lymphocytic Leukemia.

RHAMM/CD168 Is a Novel Leukemia Associated Antigen with Prognostic Value for Patients with B-Cell Chronic Lymphocytic Leukemia.

Clinical Efficacy and Safety of Combined Thalidomide and Fludarabine Therapy in B-Cell Chronic Lymphocytic Leukemia Patients.

High Frequency of T Regulatory Cells in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Is Decreased by Thalidomide and Fludarabine Treatment.

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM/CD168) Is a Potential Target for Immunotherapy of Patients with B-Cell Chronic Lymphocytic Leukemia.

ZAP-70 Versus CD38 Expression as the Prognostic Factors in B-Cell Chronic Lymphocytic Leukemia.

Plasma and Intracellular Concentration of TNF and Its Receptors in Peripheral Blood and Bone Marrow in Different Stages of B-CLL.

Dendritic Cells (DC) Generated from AML Blasts Express Leukemia Associated Antigens Eliciting Specific Cytotoxic T Cell Responses in the Autologous Host after DC Vaccination.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only